Who should pay for gene therapy?

As gene therapy trials show promise to cure or ameliorate several diseases, it is time to explore ways to pay for the treatments, according to a new commentary. Noting the potential of gene therapy to be a one-time treatment for rare and serious diseases that otherwise cost hundreds of thousands, if not millions, of dollars in chronic care over a lifetime, the authors suggest several models for valuing, pricing and developing gene therapy.